Tarsus Pharmaceuticals (TARS) Income Statement (2019 - 2026)
Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for Tarsus Pharmaceuticals (TARS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||
Total Revenue | 162M (+6.84%) | 152M (+27.78%) | 119M (+15.62%) | 103M (+31.06%) | 78M (+17.95%) | 66M (+38.01%) | 48M (+17.91%) | 41M (+47.81%) | 28M (+111.09%) | 13M (+599.47%) | 1.87M | - | 2.50M (-75.00%) | 10M | - | 15M (+2729.63%) | 540K (+58.82%) | 340K (-72.58%) | 1.24M (-94.37%) | 22M (-34.13%) | 33M | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 22M (+23.89%) | 18M (+10.81%) | 16M (+4.43%) | 16M (+8.19%) | 14M (-14.58%) | 17M (+39.08%) | 12M (-1.54%) | 12M (+2.07%) | 12M (-9.32%) | 13M (+9.91%) | 12M (-3.51%) | 13M (+1.54%) | 12M (+23.23%) | 10M (-8.07%) | 11M (+13.65%) | 9.60M (-20.53%) | 12M (+50.25%) | 8.04M (-21.25%) | 10M (+41.81%) | 7.20M (-55.72%) | 16M (+114.23%) | 7.59M (-5.01%) | 7.99M (+359.20%) | 1.74M (+15.23%) | 1.51M (-45.29%) | 2.76M (+590.00%) | 400K | - | - |
Selling General And Administrative | 136M (+4.40%) | 131M (+20.30%) | 109M (+5.46%) | 103M (+21.19%) | 85M (+23.13%) | 69M (+19.20%) | 58M (-1.50%) | 59M (+13.98%) | 52M (+19.93%) | 43M (+41.85%) | 30M (+49.58%) | 20M (+34.24%) | 15M (+3.21%) | 15M (+22.02%) | 12M (+15.51%) | 10M (+30.57%) | 7.95M (+17.43%) | 6.77M (+1.50%) | 6.67M (-1.77%) | 6.79M (+31.59%) | 5.16M (+32.65%) | 3.89M (+80.93%) | 2.15M (+40.52%) | 1.53M (+150.82%) | 610K (-32.22%) | 900K (+291.30%) | 230K | - | - |
Operating Expenses | 168M (+5.35%) | 160M (+19.82%) | 133M (+6.72%) | 125M (+19.33%) | 105M (+15.18%) | 91M (+23.95%) | 73M (-1.12%) | 74M (+13.49%) | 65M (+13.51%) | 58M (+34.38%) | 43M (+30.44%) | 33M (+19.56%) | 27M (+9.54%) | 25M (+9.38%) | 23M (+11.76%) | 21M (+2.19%) | 20M (+35.63%) | 15M (-12.74%) | 17M (+14.99%) | 15M (-35.12%) | 23M (+97.91%) | 11M (+13.21%) | 10M (+211.04%) | 3.26M (+53.77%) | 2.12M (-42.23%) | 3.67M (+482.54%) | 630K | - | - |
Depreciation And Amortization | 200K (-16.67%) | 240K (+20.00%) | 200K (0.00%) | 200K (-9.09%) | 220K (0.00%) | 220K (+10.00%) | 200K (+100.00%) | 100K (-41.18%) | 170K (-29.17%) | 240K (+20.00%) | 200K (0.00%) | 200K (+100.00%) | 100K (+233.33%) | 30K (-70.00%) | 100K (0.00%) | 100K (0.00%) | 100K (+900.00%) | 10K (-90.00%) | 100K (-23.08%) | 130K (+116.67%) | 60K (+50.00%) | 40K (+100.00%) | 20K (0.00%) | 20K (0.00%) | 20K (-33.33%) | 30K (+200.00%) | 10K | - | - |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -6.12M (-23.31%) | -7.98M (-45.08%) | -14.53M (-34.49%) | -22.18M (-15.60%) | -26.28M (+7.62%) | -24.42M (-2.94%) | -25.16M (-24.44%) | -33.30M (-11.62%) | -37.68M (-15.23%) | -44.45M (+8.60%) | -40.93M (+24.71%) | -32.82M (+31.54%) | -24.95M (+65.67%) | -15.06M (-34.26%) | -22.91M (+338.89%) | -5.22M (-73.26%) | -19.52M (+35.09%) | -14.45M (-7.96%) | -15.70M | 7.28M (-32.03%) | 11M | -11.48M (+13.21%) | -10.14M (+211.04%) | -3.26M (+53.77%) | -2.12M (-42.08%) | -3.66M (+480.95%) | -630.00K | - | - |
Ebit | -6.12M (-23.31%) | -7.98M (-45.08%) | -14.53M (-34.49%) | -22.18M (-15.60%) | -26.28M (+7.62%) | -24.42M (-2.94%) | -25.16M (-24.44%) | -33.30M (-11.62%) | -37.68M (-15.23%) | -44.45M (+8.60%) | -40.93M (+24.71%) | -32.82M (+31.54%) | -24.95M (+65.67%) | -15.06M (-34.26%) | -22.91M (+338.89%) | -5.22M (-73.26%) | -19.52M (+35.09%) | -14.45M (-7.96%) | -15.70M | 7.28M (-32.03%) | 11M | -11.48M (+13.21%) | -10.14M (+211.04%) | -3.26M (+53.77%) | -2.12M (+94.50%) | -1.09M (+73.02%) | -630.00K (-24.10%) | -830.00K (-52.30%) | -1.74M |
EBITDA | -5.92M (-23.51%) | -7.74M (-45.99%) | -14.33M (-34.80%) | -21.98M (-15.66%) | -26.06M (+7.64%) | -24.21M (-3.00%) | -24.96M (-24.82%) | -33.20M (-11.49%) | -37.51M (-15.15%) | -44.21M (+8.54%) | -40.73M (+24.86%) | -32.62M (+31.27%) | -24.85M (+65.34%) | -15.03M (-34.11%) | -22.81M (+345.51%) | -5.12M (-73.64%) | -19.42M (+34.49%) | -14.44M (-7.44%) | -15.60M | 7.41M (-31.26%) | 11M | -11.43M (+12.94%) | -10.12M (+211.38%) | -3.25M (+54.76%) | -2.10M (+98.11%) | -1.06M (+70.97%) | -620.00K (-25.30%) | -830.00K (-52.30%) | -1.74M |
Other Income / Expenses | |||||||||||||||||||||||||||||
Interest Expense | 2.13M (-3.62%) | 2.21M (-2.64%) | 2.27M (+1.34%) | 2.24M (+1.36%) | 2.21M (-4.33%) | 2.31M (-5.33%) | 2.44M (+15.64%) | 2.11M (+115.31%) | 980K (-1.01%) | 990K (+15.12%) | 860K (+4.88%) | 820K (+20.59%) | 680K (-4.23%) | 710K (+12.70%) | 630K (+16.67%) | 540K (+68.75%) | 320K | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | - | - | - | - | - | 980K | - | - | -980.00K (-1.01%) | -990.00K (+15.12%) | -860.00K (+6.17%) | -810.00K (+19.12%) | -680.00K (-4.23%) | -710.00K (+12.70%) | -630.00K (+16.67%) | -540.00K (+68.75%) | -320.00K | - | - | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | -90.00K (-55.00%) | -200.00K | 100K | -140.00K (+75.00%) | -80.00K (-61.90%) | -210.00K | 70K | -60.00K (-66.67%) | -180.00K | 270K | -50.00K (0.00%) | -50.00K | 10K (-88.89%) | 90K | -10.00K | 110K (+175.00%) | 40K | -70.00K | 10K | -40.00K (+33.33%) | -30.00K | - | - | - | - | -370.00K (+640.00%) | -50.00K | - | - |
Net Income | |||||||||||||||||||||||||||||
Income Before Tax | - | -64.36M | - | - | - | -115.55M | - | - | - | -135.89M | - | - | - | -62.09M | - | - | - | -13.77M | - | - | - | -26.81M | - | - | - | - | - | - | - |
Income Tax Expense | 2.35M (+14.08%) | 2.06M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50K | -340.00K | 30K (-90.32%) | 310K | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -6.97M (-16.73%) | -8.37M (-33.47%) | -12.58M (-38.15%) | -20.34M (-19.03%) | -25.12M (+8.70%) | -23.11M (-1.32%) | -23.42M (-29.65%) | -33.29M (-6.83%) | -35.73M (-14.73%) | -41.90M (+7.02%) | -39.15M (+24.60%) | -31.42M (+34.16%) | -23.42M (+72.21%) | -13.60M (-39.58%) | -22.51M (+292.16%) | -5.74M (-71.64%) | -20.24M (+36.30%) | -14.85M (-5.41%) | -15.70M | 6.35M (-38.82%) | 10M | -11.47M (+13.12%) | -10.14M (+212.00%) | -3.25M (+65.82%) | -1.96M (+39.01%) | -1.41M (+107.35%) | -680.00K (-18.07%) | -830.00K (-52.30%) | -1.74M |
Net Income | -6.97M (-16.73%) | -8.37M (-33.47%) | -12.58M (-38.15%) | -20.34M (-19.03%) | -25.12M (+8.70%) | -23.11M (-1.32%) | -23.42M (-29.65%) | -33.29M (-6.83%) | -35.73M (-14.73%) | -41.90M (+7.02%) | -39.15M (+24.60%) | -31.42M (+34.16%) | -23.42M (+72.21%) | -13.60M (-39.58%) | -22.51M (+292.16%) | -5.74M (-71.64%) | -20.24M (+36.30%) | -14.85M (-5.41%) | -15.70M | 6.35M (-38.82%) | 10M | -11.47M (+13.12%) | -10.14M (+212.00%) | -3.25M (+65.82%) | -1.96M (+39.01%) | -1.41M (+107.35%) | -680.00K (-18.07%) | -830.00K (-52.30%) | -1.74M |
Comprehensive Income Net Of Tax | -7.65M (-88.45%) | -66.22M (+437.06%) | -12.33M (-39.53%) | -20.39M (-19.12%) | -25.21M (-78.15%) | -115.37M (+403.80%) | -22.90M (-31.44%) | -33.40M (-6.68%) | -35.79M (-73.65%) | -135.82M (+247.10%) | -39.13M (+24.70%) | -31.38M (+34.05%) | -23.41M (-62.34%) | -62.16M (+176.02%) | -22.52M (+292.33%) | -5.74M (-71.64%) | -20.24M (+46.35%) | -13.83M (-11.91%) | -15.70M | 6.35M (-38.82%) | 10M | -26.81M (+164.40%) | -10.14M (+212.00%) | -3.25M (+65.82%) | -1.96M (-58.03%) | -4.67M (+586.76%) | -680.00K | - | - |